Encompass Health Corporation HLS
Set alert
No live quote for HLS yet.
- Open
- 49.31
- Prev close
- 49.31
- Mkt cap
- 4.86B
- Vol
- 406.04K
- Avg vol
- 662.52K
- EPS
- 2.77
- P/E
- 17.87
- Div yield
- 2.02%
More statistics
- Low
- 49.21
- High
- 50.06
- Forward P/E
- 17.04
- Beta
- 0.04
- Short ratio
- 3.68
- Inst. own
- 0.00%
- Dividend
- 1.00
- Ex-div date
- Dec 28, 2017
- 50-d avg
- 30.83
- 200-d avg
- 43.34
- 1y target
- 51.82
Analyst view
Consensus: buy
Buy
Price target (mean) 51.82
- Target (low)
- 40.00
- Target (mean)
- 51.82
- Target (high)
- 58.00
Ratings (0m) 12 8 buy · 3 hold · 1 sell
- Strong buy2
- Buy6
- Hold3
- Sell1
- Strong sell0
Recommendation trend
- This month 12
- 1 month ago 12
- 2 months ago 12
- 3 months ago 12
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.65 | 0.62 – 0.71 | 0.72 | -9.7% | 1.00B | +5.6% | 13 |
| Next quarter | 0.70 | 0.67 – 0.72 | 0.70 | 0.0% | 1.03B | +5.5% | 11 |
| Current year | 2.71 | 2.69 – 2.73 | 2.67 | +1.5% | 3.94B | +6.4% | 11 |
| Next year | 2.90 | 2.82 – 3.00 | 2.71 | +7.0% | 4.17B | +5.7% | 13 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 1, 2017 | Mizuho | Upgrade | Neutral | Buy |
| Aug 30, 2017 | Stephens & Co. | Initiated | — | Overweight |
| Jun 14, 2017 | KeyBanc | Initiated | — | Sector Weight |
| Feb 13, 2017 | Craig-Hallum | Initiated | — | Buy |
| Feb 12, 2017 | Craig-Hallum | Initiated | — | Buy |
| Jan 3, 2017 | PiperJaffray | Initiated | — | Neutral |
| Nov 8, 2016 | Mizuho | Downgrade | — | Neutral |
| Jul 31, 2016 | SunTrust Robinson Humphrey | Maintained | — | Buy |
| Jun 26, 2016 | Barclays | Downgrade | — | Underweight |
| Oct 29, 2015 | SunTrust Robinson Humphrey | Maintained | — | Buy |
| Oct 29, 2015 | Barclays | Maintained | — | Equal-Weight |
| Oct 28, 2015 | Stifel Nicolaus | Downgrade | — | Hold |
| Oct 7, 2015 | Barclays | Maintained | — | Equal-Weight |
| Jul 29, 2015 | Stifel Nicolaus | Maintained | — | Buy |
| Jul 1, 2015 | JMP Securities | Upgrade | — | Outperform |
| Jun 11, 2015 | Deutsche Bank | Maintained | — | Hold |
| Jun 9, 2015 | Wedbush | Initiated | — | Neutral |
| Jun 7, 2015 | UBS | Maintained | — | Neutral |
| Feb 25, 2015 | Barclays | Maintained | — | Equal-Weight |
| Jan 7, 2015 | Barclays | Maintained | — | Equal-Weight |
| Jul 29, 2014 | Barclays | Maintained | — | Equal-Weight |
| Jul 28, 2014 | UBS | Maintained | — | Neutral |
| Jul 28, 2014 | Mizuho | Maintained | — | Buy |
| Mar 31, 2014 | Barclays | Initiated | — | Equal-Weight |
| Feb 19, 2014 | Stifel Nicolaus | Maintained | — | Buy |
| Jan 5, 2014 | Raymond James | Downgrade | — | Market Perform |
| Nov 21, 2013 | Stifel Nicolaus | Maintained | — | Buy |
| Oct 29, 2013 | Deutsche Bank | Maintained | — | Hold |
| Oct 20, 2013 | Stifel Nicolaus | Maintained | — | Buy |
| Jul 25, 2013 | Susquehanna | Maintained | — | Positive |